ArticleTechnology in cancer research & treatment
Salivary SIRT3 Levels in Gutka and Alcohol Consumers: A Cross-Sectional Study on Habit-Associated Molecular Changes.
Article in Technology in cancer research & treatment. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BackgroundSirtuin-3 (SIRT3) regulates the production of cellular reactive oxygen species (ROS). This study aims to elucidate the molecular mechanisms involved in oral lesion development by exploring the relationship between SIRT3 expression, gutka consumption, and oral disease progression, with the objective of identifying potential biomarkers for early detection and risk assessment.MethodsA cross-sectional study was conducted among individuals who regularly underwent oral health check-ups, excluding patients with premalignant and oral cancers from the study. Participants were categorized into three groups: Case 1 (gutka and alcohol consumers), Case 2 (gutka consumers without alcohol), and Control (non-consumers). Unstimulated saliva samples were collected and analysed using ELISA to measure SIRT3 levels. Statistical comparisons were performed using ANOVA followed by post hoc Tukey testsResultsThe mean SIRT3 levels were 7.57 ± 3.23 ng/mL (Case 1), 8.17 ± 2.87 ng/mL (Case 2), and 9.9 ± 2.78 ng/mL (control). The differences between the groups were statistically significant (p = .036), with the greatest difference observed between the case 1 group and the control group.ConclusionSIRT3 levels were lowest in individuals who consumed gutka and alcohol and were significantly lower than those in the control group. These findings suggest a potential negative impact of gutka and alcohol consumption on SIRT3 levels.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.